Mammography

Clinicians were more likely to discuss breast cancer screening issues with patients following an educational intervention.

US women experience higher false-positive mammography rates than do European women.

Breast cancer screening for women aged 50 to 74 does reduce breast cancer mortality.

Case History: 55-year-old female with left breast, upper, central lump.

Case History: 67-year-old female with progressive increase in size of left breast for five years.

Supplemental or alternative screening for breast cancer does not need to be an automatic process for women with dense breast tissue.

Imaging examinations interpreted by diagnostic radiology residents and fellows have increased.

Case History: 65-year-old woman with right upper outer quadrant painless mass.

MRI may determine which women at risk for breast cancer most need supplemental screening, based on their BPE levels.

44-year-old woman presents for screening mammogram.

Coauthor of study discusses the costs of overdiagnosis and overtreatment of breast cancer.

Digital breast tomosynthesis is effective in detecting breast cancer overall, but particularly so in dense breast tissue.

The tomosynthesis option for the Siemens’ MAMMOMAT Inspiration digital mammography system received FDA approval.

A presentation at ARRS looked at whether surgeons are really following the USPSTF guidelines.

USPSTF released a draft recommendation statement on breast cancer screening; little has changed since the last statement in 2009.

Weighing the costs of breast cancer screening and the economic impact of false positives.

Full field digital mammography, performed instead of screen film mammography, finds fewer interval breast cancers.

Use peer review in radiology as an opportunity for improvement, said David A. Koff, MD at ECR 2015.

Patients with breast cancer and very low mammographic breast density have a poorer prognosis.

Inappropriate imaging for low-risk prostate cancer and low-risk breast cancer varies by region.

Two automated volumetric methods were superior in measuring breast density.

The issue of overdetection of cancer from screening must be addressed sooner than later, say experts.

Mammography would be more accurate and comfortable for patients with mammographic pressure standardization.

Localized correlated spectroscopy may show signs of biochemical abnormalities, possibly signaling breast cancer among women with BRCA gene.